In the last decade, extended-spectrum cephalosporin and carbapenem resistant Gram-
negative bacilli (GNB) have been extensively reported in the literature as being …

Acinetobacter baumannii is a problematic pathogen of global concern. It causes multiple
types of infection, especially among immunocompromised individuals in intensive care units …

Acinetobacter baumannii is a Gram-negative coccobacillus responsible for severe hospital-
acquired infections, particularly in intensive care units (ICUs). The current study was …

Aim Acinetobacter baumannii is a well‐known nosocomial pathogen that has been isolated
from different clinical sources. This pathogen also causes community‐acquired infections …

The progressive increase in the resistance rates to first-and second-line antibiotics has
forced the reuse of colistin as last-line treatment for Acinetobacter baumannii infections, but …

Background Reliable phenotypic antimicrobial susceptibility testing can be a challenge in
clinical settings in low-and middle-income countries. WGS is a promising approach to …

Abstract Carbapenem resistance in Enterobacteriaceae, Acinetobacter baumannii, and
Pseudomonas aeruginosa is increasing worldwide, which led the WHO to list these bacteria …

Abstract Background Multidrug resistant Acinetobacter baumannii is one of the major
infection agents causing nosocomial pneumonia. Therefore, new therapeutic approaches …

The advent of multidrug-resistant (MDR) bacteria poses a major threat to public health,
garnering attention to novel antibiotic replacements. Endolysin, a bacteriophage-derived cell …

Acinetobacter baumannii is an opportunistic pathogen that is increasingly responsible for
hospital-acquired infections. The increasing prevalence of carbapenem resistant A …